Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Galanthamine Hydrobromide Orally Disintegrating Tablets

Approval Number

国药准字H20244022

Company广东东阳光药业股份有限公司

Registration Date

June 18, 2024

Drug Information

Generic Name

氢溴酸加兰他敏口腔崩解片

Dosage Form

片剂

Strength

8mg（按C₁₇H₂₁NO₃计）

Drug Type

化学药品

Registration Date

June 18, 2024

Company Information

Applicant Company

Company Name广东东阳光药业股份有限公司

Company Address

广东省东莞市松山湖园区工业北路1号

Manufacturing Company

Company Name宜昌东阳光长江药业股份有限公司

Company Address

湖北省宜昌宜都市滨江路38号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy